Kannan Thanikachalam

Assistant Professor

Roswell Park Comprehensive Cancer Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Kannan Thanikachalam is an Assistant Professor at Roswell Park Comprehensive Cancer Center in the United States. His research focuses on pancreatic cancer, with recent publications highlighting the use of Tumor Treating Fields in combination with chemotherapy, the prognostic significance of MUC5AC in pancreatic ductal adenocarcinoma, and the impact of neoadjuvant therapies. Additionally, he has contributed to the understanding of treatment disparities in multiple myeloma and provided insights into COVID-19's effects on cancer patients.

Articles (8)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Ashish Manne

The Ohio State University Comprehensive Cancer Center

UNITED STATES

View details

Eric D. Miller

The Ohio State University Comprehensive Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kannan Thanikachalam

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study.

Prognostic significance of serum MUC5AC in resected pancreatic ductal adenocarcinoma: initial insights.

Mature MUC5AC Expression in Resected Pancreatic Ductal Adenocarcinoma Predicts Treatment Response and Outcomes

Sezary Syndrome: A Case Report and Review of Current Therapeutics.

Disparities in Utilization of Autologous Stem Cell Transplantation as Consolidative Therapy for Multiple Myeloma: A Single Institution Retrospective Review.

Desperate times, desperate measures: successful use of chemotherapy in treatment of haemophagocytic lymphohistiocytosis (HLH) due to disseminated histoplasmosis.

COVID-19 and Cancer: Lessons Learnt from a Michigan Hotspot

Neoadjuvant Phase II Trial of Chemoradiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer.

Collaborators (2)

Ashish Manne

Eric D. Miller

Make your next move.